Search research articles
Contact Us
Filters
Showing results (41-50 of 104) with videos related to
Page
of 11
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer
Ning Wang, Kimberley J Reeves, Hannah K Brown, et al.
Experimental Hematology
|
June 16, 2025
Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism
Justine R Clark, Vasilios Panagopoulos, Jacqueline E Noll, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 7, 2003
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival
Peter I Croucher, Raeve De Hendrik, Mark J Perry, et al.
Cancer Research
|
May 15, 2007
Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma
Karin Vanderkerken, Satya Medicherla, Les Coulton, et al.
British Journal of Haematology
|
November 17, 2006
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Evangelos Terpos, Deborah J Heath, Amin Rahemtulla, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2008
Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma
Deborah J Heath, Andrew D Chantry, Clive H Buckle, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 24, 2014
Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models
Ning Wang, Freyja E Docherty, Hannah K Brown, et al.
Plos One
|
April 11, 2015
N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models
Christopher T Esapa, Fadil M Hannan, Valerie N Babinsky, et al.
Breast Cancer Research and Treatment
|
September 13, 2005
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?
Ingunn Holen, Simon S Cross, Helen L Neville-Webbe, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 18, 2019
Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization
Konstantin Horas, Yu Zheng, Colette Fong-Yee, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 104) with videos related to
Sort By:
Page
of 11
Journal of Experimental & Clinical Cancer Research : CR
|
October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer
Ning Wang, Kimberley J Reeves, Hannah K Brown, et al.
Experimental Hematology
|
June 16, 2025
Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism
Justine R Clark, Vasilios Panagopoulos, Jacqueline E Noll, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 7, 2003
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival
Peter I Croucher, Raeve De Hendrik, Mark J Perry, et al.
Cancer Research
|
May 15, 2007
Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma
Karin Vanderkerken, Satya Medicherla, Les Coulton, et al.
British Journal of Haematology
|
November 17, 2006
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Evangelos Terpos, Deborah J Heath, Amin Rahemtulla, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2008
Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma
Deborah J Heath, Andrew D Chantry, Clive H Buckle, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 24, 2014
Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models
Ning Wang, Freyja E Docherty, Hannah K Brown, et al.
Plos One
|
April 11, 2015
N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models
Christopher T Esapa, Fadil M Hannan, Valerie N Babinsky, et al.
Breast Cancer Research and Treatment
|
September 13, 2005
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?
Ingunn Holen, Simon S Cross, Helen L Neville-Webbe, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 18, 2019
Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization
Konstantin Horas, Yu Zheng, Colette Fong-Yee, et al.
Page
of 11